Another record high sales revenue of NOK 16.6m
Minor fCAL sales setback due to Covid-19
Cystatin C sales revenue was record high in Q2
Sales of GCAL and fPELA could secure higher growth in H2/20 + H1/21
21 Aug 2020
Continued growth in revenue
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Continued growth in revenue
Another record high sales revenue of NOK 16.6m
Minor fCAL sales setback due to Covid-19
Cystatin C sales revenue was record high in Q2
Sales of GCAL and fPELA could secure higher growth in H2/20 + H1/21